Contrast Enhanced Ultrasound imaging to support prostate cancer brachytherapy treatment and follow up after treatment

Contrast Enhanced Ultrasound imaging to support prostate cancer brachytherapy treatment and follow up after treatment - contrast enhanced ultrasound of prostate cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30917

Enrollment

Registered

2007-09-06

Start date

2007-05-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer prostate carcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Biopsy proven prostate cancer, treatment with brachytherapy

Exclusion criteria

Exclusion criteria: severe cardiac problems, severe hypertension

Design outcomes

Primary

Measure	Time frame
Oncological outcomes of adjusted radiation dose with prostate brachytherapy based on perfusion imaging outcomes.	—

Secondary

Measure	Time frame
What happens with prostate blood perfusion after treatmetn with prostate brachytherapy?	—

Countries

Netherlands

Outcome results